These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36066183)

  • 41. National survey of alcoholic liver disease in Japan (1968-91).
    Takada A; Tsutsumi M
    J Gastroenterol Hepatol; 1995; 10(5):509-16. PubMed ID: 8963025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
    J Hepatol; 1994 Dec; 21(6):1006-11. PubMed ID: 7699220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Women with Cirrhosis: Prevalence, Natural History, and Management.
    Giard JM; Terrault NA
    Gastroenterol Clin North Am; 2016 Jun; 45(2):345-58. PubMed ID: 27261903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis.
    Jepsen P; Ott P
    Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):651-3. PubMed ID: 23237248
    [No Abstract]   [Full Text] [Related]  

  • 47. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
    Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
    J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Alcoholic liver disease: international morphologic classification. A critical analysis].
    Mincis M
    Arq Gastroenterol; 1983; 20(2):63-8. PubMed ID: 6318704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma in the setting of alcohol-related liver disease.
    Ganne-Carrié N; Nahon P
    J Hepatol; 2019 Feb; 70(2):284-293. PubMed ID: 30658729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Alcohol-related liver diseases in the aged].
    Santonastaso M; Zanatta N; Cioffi A; Garbelotto R; Cecchetti E
    Recenti Prog Med; 2000 Mar; 91(3):113-5. PubMed ID: 10763341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type and cause of liver disease in Korea: single-center experience, 2005-2010.
    Lee SS; Byoun YS; Jeong SH; Kim YM; Gil H; Min BY; Seong MH; Jang ES; Kim JW
    Clin Mol Hepatol; 2012 Sep; 18(3):309-15. PubMed ID: 23091812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver disease in Europe.
    Burroughs A; McNamara D
    Aliment Pharmacol Ther; 2003 Nov; 18 Suppl 3():54-9. PubMed ID: 14531742
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France.
    Goudeau A; Maupas P; Dubois F; Coursaget P; Bougnoux P
    Prog Med Virol; 1981; 27():26-34. PubMed ID: 6262868
    [No Abstract]   [Full Text] [Related]  

  • 57. A decade of rising alcoholic liver disease hospital admissions and deaths in Irish hospitals, 2007-2016: a retrospective cross-sectional analysis.
    Armstrong PR; Ring É; MacNicholas R
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):671-677. PubMed ID: 34985049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term follow-up study of alcoholic liver disease].
    Kato K; Nishimura D; Sano H; Katada N; Sugimoto Y; Noba H; Yoshino M; Samori T; Mitani Y; Takeichi M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1829-36. PubMed ID: 2174475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.